Grapevine, TX, United States of America

Michael E Stern

This inventor holds 3 USPTO granted patents. Top assignees: Alcon Laboratories, Inc., Other. Active years: 1987-1993.


% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • McLean, VA (US) (1987)
  • Grapevine, TX (US) (1990 - 1993)

Company Filing History:


Years Active: 1987-1993

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michael E Stern: Innovator in Surgical Solutions

Introduction

Michael E Stern is a notable inventor based in Grapevine, TX (US). He holds a total of 3 patents that focus on advancements in surgical solutions. His work has significantly contributed to the fields of ophthalmic, neural, cardiovascular, and otic surgery.

Latest Patents

One of his latest patents involves tissue irrigating solutions. These solutions contain thiol or disulfide compounds in physiologically acceptable salt solutions. They are particularly useful during surgery to stabilize affected tissue. Additionally, he has developed methods for preventing and treating corneal haze resulting from laser irradiation. These methods include the administration of compositions that act as wound healing modulators to the eye.

Career Highlights

Throughout his career, Michael has worked with various companies, including Alcon Laboratories, Inc. His innovative contributions have made a significant impact on surgical practices and patient outcomes.

Collaborations

Michael has collaborated with notable individuals in his field, including Stella M Robertson and Herman M Kunkle, Jr. Their combined expertise has furthered the development of effective surgical solutions.

Conclusion

Michael E Stern's contributions to surgical innovations demonstrate his commitment to improving medical practices. His patents reflect a deep understanding of the needs in surgical environments, ultimately enhancing patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…